Literature DB >> 19215835

Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure.

Wilfried Mullens1, Tanya Verga1, Richard A Grimm1, Randall C Starling1, Bruce L Wilkoff1, W H Wilson Tang2.   

Abstract

OBJECTIVES: Our aim was to determine the potential hemodynamic contributions of cardiac resynchronization therapy (CRT) in patients admitted for advanced decompensated heart failure.
BACKGROUND: CRT restores synchrony of the heart resulting in hemodynamic support that can facilitate the reversal of left ventricular (LV) remodeling in some patients.
METHODS: A total of 40 consecutive patients with advanced decompensated heart failure and CRT implanted >3 months, admitted due to hemodynamic derangements, underwent simultaneous comprehensive echocardiographic and invasive hemodynamic evaluation under different CRT settings.
RESULTS: All patients (mean LV ejection fraction 22 +/- 7%, LV end-diastolic volume 323 +/- 140 ml, 40% ischemic) had experienced progressive cardiac remodeling despite adequate LV lead positions and continuous biventricular pacing. A significant worsening of hemodynamics was observed immediately when CRT was programmed OFF in the majority (88%) of patients (systolic blood pressure: 105 +/- 12 mm Hg to 98 +/- 13 mm Hg; pulmonary capillary wedge pressure: 17 +/- 6 mm Hg to 21 +/- 7 mm Hg; cardiac output: 4.6 +/- 1.4 l/min.m(2) to 4.0 +/- 1.1 l/min.m(2); all p < 0.001). Worsening of hemodynamics coincided with reappearance of significant electrical (QRS width 161 +/- 29 ms to 202 +/- 39 ms, p < 0.001) and intraventricular mechanical dyssynchrony (15 +/- 26 ms to 57 +/- 41 ms, p < 0.001), together with a significant reduction in diastolic filling time (377 +/- 138 ms to 300 +/- 118 ms, p < 0.001).
CONCLUSIONS: Despite progressive cardiac remodeling and decompensation, chronic CRT continues to provide hemodynamic augmentation in the failing heart in most patients. Our data suggest that disease progression may not be explained by diminished beneficial hemodynamic contributions of successful resynchronization.

Entities:  

Mesh:

Year:  2009        PMID: 19215835     DOI: 10.1016/j.jacc.2008.08.079

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

1.  Acute and chronic response to CRT in narrow QRS patients.

Authors:  Tim Donahue; Imran Niazi; Angel Leon; Michael Stucky; Keith Herrmann
Journal:  J Cardiovasc Transl Res       Date:  2011-12-30       Impact factor: 4.132

Review 2.  Echocardiography, dyssynchrony, and the response to cardiac resynchronization therapy.

Authors:  Cheuk-Man Yu; John E Sanderson; John Gorcsan
Journal:  Eur Heart J       Date:  2010-08-13       Impact factor: 29.983

3.  Cardiac Resynchronization Therapy in CKD Stage 4 Patients.

Authors:  Ulas Höke; Mand J H Khidir; Enno T van der Velde; Martin J Schalij; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-25       Impact factor: 8.237

Review 4.  Optimizing CRT - Do We Need More Leads and Delivery Methods.

Authors:  Pieter Martens; Frederik Hendrik Verbrugge; Wilfried Mullens
Journal:  J Atr Fibrillation       Date:  2015-04-30

Review 5.  How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection?

Authors:  Laszlo Buga
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

Review 6.  Devices in the management of advanced, chronic heart failure.

Authors:  William T Abraham; Sakima A Smith
Journal:  Nat Rev Cardiol       Date:  2012-12-11       Impact factor: 32.419

7.  A novel fluoroscopic method of measuring right-to-left interlead distance as a predictor of reverse left ventricular remodeling after cardiac resynchronization therapy.

Authors:  Gregorio Covino; Mario Volpicelli; Pietro Belli; Gennaro Ratti; Paolo Tammaro; Ciro Provvisiero; Carmine Ciardiello; Luca Auricchio; Ciro Fiorentino; Paolo Capogrosso
Journal:  J Interv Card Electrophysiol       Date:  2013-11-29       Impact factor: 1.900

8.  Acute recoordination rather than functional hemodynamic improvement determines reverse remodelling by cardiac resynchronisation therapy.

Authors:  Philippe C Wouters; Geert E Leenders; Maarten J Cramer; Mathias Meine; Frits W Prinzen; Pieter A Doevendans; Bart W L De Boeck
Journal:  Int J Cardiovasc Imaging       Date:  2021-02-05       Impact factor: 2.357

Review 9.  What is treatment success in cardiac resynchronization therapy?

Authors:  Paul W X Foley; Francisco Leyva; Michael P Frenneaux
Journal:  Europace       Date:  2009-11       Impact factor: 5.214

Review 10.  Sacubitril/Valsartan in the Management of Heart Failure Patients with Cardiac Implantable Electronic Devices.

Authors:  Sijing Cheng; Nixiao Zhang; Wei Hua
Journal:  Am J Cardiovasc Drugs       Date:  2020-10-28       Impact factor: 3.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.